By Max Li, May 18, 2026, grassrootecho.com
Dr. Ming Wang is a personal friend of mine, and one thing I can say from knowing him is this: he is truly unselfish. His story of the amniotic membrane contact lens, or AMCL, is not only a story of medical invention. It is a story of what can happen when an inventor decides that healing people matters more than owning every possible benefit.
The AMCL technology was designed to help the surface of the eye heal. According to Wang Vision's AMCL page, Dr. Wang invented the technology, published scientific work about it, and obtained two U.S. patents: U.S. Patent Nos. 5,932,205 and 6,143,315. The same page describes AMCL as a natural healing lens that uses the scarless fetal wound-healing properties of the amniotic membrane to help damaged ocular surfaces recover.
What makes the story extraordinary is not only the invention. It is what Dr. Wang chose to do with it.
From Invention to Public Benefit
The AMCL page describes a long development journey. In 1996, Dr. Wang worked on amniotic membrane transplantation experiments with Dr. Scheffer Tseng. In 1999, Dr. Wang and Chris Adams obtained two U.S. patents on AMCL. In 2000, related scientific work was published in the Journal of Cataract & Refractive Surgery. That same year, Dr. Wang founded EyeVU with Vanderbilt University to develop AMCL and manufacture the world's first AMCL prototype.
The story continued through grant support, commercialization, and wider clinical adoption. By 2012, the AMCL page reported that more than 500 U.S. eye doctors had used the AmbioDisk AMCL product. But the deeper point is that a technology born from years of disciplined research eventually became available to many doctors and patients beyond the original inventor's clinic.
In an interview on Dr. Wang's own site, he explained that after receiving the two patents, he put the patent information online and taught more than 10,000 eye doctors pro bono how to use the technology. In that interview, he said that AMCL has become a $5 billion industry. Whether one looks at it as medical innovation, entrepreneurship, or service, that is a remarkable arc.
The Meaning of Donating an Idea
Patents usually represent control. They are legal tools that allow an inventor to protect an invention, license it, monetize it, or prevent others from using it without permission. There is nothing wrong with that. Inventors deserve protection, and innovation often requires financial incentives.
But sometimes an invention touches human need so directly that the inventor faces a moral question: should I maximize private return, or should I make the knowledge easier for others to use? Dr. Wang's AMCL story is powerful because he chose the road of public benefit. He did not merely invent something useful. He helped spread the knowledge.
That is why I call him unselfish. It is easy to talk about helping people after success has already arrived. It is much harder to open a door when the thing behind that door has real economic value.
A generous invention does not become smaller when it is shared. Sometimes it becomes larger because more people are allowed to carry it forward.
Science, Skill, and Character
Dr. Wang is widely known as an eye surgeon, innovator, and public speaker. His personal website, drmingwang.com, presents a life that crosses science, medicine, faith, immigration, education, and philanthropy. But what impresses me most is the connection between skill and character.
Many people have talent. Fewer people use talent with humility. Many people create value. Fewer people are willing to let others participate in that value. Dr. Wang's AMCL story is a reminder that the best kind of innovation is not only technically clever. It is humanly generous
A Business Lesson Hidden Inside a Medical Story
There is also a business lesson here. We often assume that giving something away reduces its value. But in knowledge-based industries, the opposite can happen. When knowledge spreads, ecosystems form. Doctors learn. Products improve. Patients benefit. A market becomes educated. A technique becomes trusted.
The result can be much larger than what one person could have built alone. That is the paradox of generosity in innovation: by not holding too tightly, the idea may travel farther.
For entrepreneurs, technologists, and inventors, this does not mean every patent should be given away. But it does mean we should ask a deeper question: what is the highest purpose of this invention? Is it only to create a private asset, or can it become part of a larger public good?
Conclusion
Dr. Ming Wang's AMCL story is one I admire because it combines invention, courage, and generosity. Two patents could have been treated only as private property. Instead, they became part of a much larger movement in eye care.
Right now, according to Dr. Wang's own account, AMCL is a 5 billion dollar business. But to me, the most important number is not the market size. The most important fact is that many doctors learned, many patients were helped, and one inventor chose not to keep the gift only for himself.
Abou the author:
Max Li
Founder, Grassrootech
This email address is being protected from spambots. You need JavaScript enabled to view it.
Max is dedicated to bridging the gap between advanced research and practical industry application. Drawing on his experience at IBM Research and Union University, he leads the development of AI solutions that drive meaningful progress.
